Cargando…

Development and validation of nomograms for predicting survival probability of patients with advanced adenocarcinoma in different EGFR mutation status

INTRODUCTION: Molecular markers are important variables in the selection of treatment for cancer patients and highly associated with their survival. Therefore, a nomogram that can predict survival probability by incorporating epidermal growth factor receptor mutation status and treatments for patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Hsi-Chieh, Tan, Elise Chia-Hui, Liao, Chih-Hsien, Lin, Zhong-Zhe, Yang, Ming-Chin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6697331/ https://www.ncbi.nlm.nih.gov/pubmed/31419239 http://dx.doi.org/10.1371/journal.pone.0220730

Ejemplares similares

Nomogram based on preoperative CT imaging predicts the EGFR mutation status in lung adenocarcinoma
por: Zhang, Guojin, et al.
Publicado: (2020)

Develop and validation a nomogram to predict the recurrent probability in patients with major salivary gland cancer
por: Lu, Chang-Hsien, et al.
Publicado: (2017)

Brain metastases in lung adenocarcinoma: impact of EGFR mutation status on incidence and survival
por: Stanic, Karmen, et al.
Publicado: (2014)

Comparison of Different Tyrosine Kinase Inhibitors for Treatment of Poor Performance Status Patients with EGFR-Mutated Lung Adenocarcinoma
por: Wu, Chiao-En, et al.
Publicado: (2022)

EGFR unusual mutation status in lung adenocarcinomas
por: Alarcão, Ana, et al.
Publicado: (2010)

Influence of the Timing of Leptomeningeal Metastasis on the Outcome of EGFR-Mutant Lung Adenocarcinoma Patients and Predictors of Detectable EGFR Mutations in Cerebrospinal Fluid
por: Liao, Pei-Ya, et al.
Publicado: (2022)

The Combination of Afatinib and Bevacizumab in Untreated EGFR-Mutated Advanced Lung Adenocarcinoma: A Multicenter Observational Study
por: Hsu, Ping-Chih, et al.
Publicado: (2020)

The Impact of Sequence of Chemotherapy and EGFR-TKI Treatment on Different EGFR Mutation Lung Adenocarcinoma
por: Chung, Fu-Tsai, et al.
Publicado: (2015)

Development and validation of novel nomograms for predicting the survival of patients after surgical resection of pancreatic ductal adenocarcinoma
por: Li, Ge, et al.
Publicado: (2020)

Development and validation of nomograms to recurrence and survival in patients with early-stage cervical adenocarcinoma
por: Wang, Xintao, et al.
Publicado: (2023)

Value of (18)F-FDG PET/CT-Based Radiomics Nomogram to Predict Survival Outcomes and Guide Personalized Targeted Therapy in Lung Adenocarcinoma With EGFR Mutations
por: Yang, Bin, et al.
Publicado: (2020)

EGFR gene-mutation status correlated with therapeutic decision making in lung adenocarcinoma
por: Ren, Yaoyao, et al.
Publicado: (2015)

Development and Validation of a Nomogram for Predicting Survival in Patients with Advanced Pancreatic Ductal Adenocarcinoma
por: Deng, Qing-Long, et al.
Publicado: (2017)

Development and validation of a nomogram with an epigenetic signature for predicting survival in patients with lung adenocarcinoma
por: Wang, Jiao, et al.
Publicado: (2020)

A real-world study comparing perioperative chemotherapy and EGFR-tyrosine kinase inhibitors for treatment of resected stage III EGFR-mutant adenocarcinoma
por: Chen, Chieh-Lung, et al.
Publicado: (2023)

Predicting the Probability of the Incidence of Maxillary Sinus Fungus Ball in Patients Using Nomogram Models
por: Fan, Yu-Hsi, et al.
Publicado: (2023)

The Impact of Acquired EGFR T790M Mutation and EGFR Circulating Cell-Free DNA on Survival in Patients with Lung Adenocarcinoma Following EGFR-TKI Therapy
por: Cheng, Wen-Chien, et al.
Publicado: (2021)

Risk Stratification Using a Novel Nomogram for 2190 EGFR-Mutant NSCLC Patients Receiving the First or Second Generation EGFR-TKI
por: Chang, John Wen-Cheng, et al.
Publicado: (2022)

Development and Validation of a Nomogram to Predict the Probability of Venous Thromboembolism in Patients with Epithelial Ovarian Cancer
por: Wang, Yuhan, et al.
Publicado: (2022)

Development and Validation of a Nomogram to Predict Survival in Pancreatic Head Ductal Adenocarcinoma After Pancreaticoduodenectomy
por: Peng, Feng, et al.
Publicado: (2021)

Development and validation of a nomogram for predicting survival in patients with non-metastatic primary adenocarcinoma of the bladder
por: Yu, Dong-Dong, et al.
Publicado: (2020)

Construction and validation of a novel nomogram to predict cancer-specific survival in patients with gastric adenocarcinoma
por: Nie, Guole, et al.
Publicado: (2023)

Score for the Overall Survival Probability of Patients With Pancreatic Adenocarcinoma of the Body and Tail After Surgery: A Novel Nomogram-Based Risk Assessment
por: He, Chaobin, et al.
Publicado: (2020)

A 5‐gene prognostic nomogram predicting survival probability of glioblastoma patients
por: Wang, Lingchen, et al.
Publicado: (2019)

Association of EGFR Tyrosine Kinase Inhibitor Treatment With Progression-Free Survival Among Taiwanese Patients With Advanced Lung Adenocarcinoma and EGFR Mutation
por: Chen, Po-Yen, et al.
Publicado: (2021)

Nomogram predicted survival of patients with adenocarcinoma of esophagogastric junction
por: Zhou, Zhangjian, et al.
Publicado: (2015)

Construction and validation of a novel prognostic nomogram for predicting overall survival in lung adenocarcinoma patients with different patterns of metastasis
por: Xiong, Ying, et al.
Publicado: (2023)

A nomogram for predicting brain metastases of EGFR-mutated lung adenocarcinoma patients and estimating the efficacy of therapeutic strategies
por: Wang, Jing, et al.
Publicado: (2021)

Brain metastasis, EGFR mutation subtype and generation of EGFR-TKI jointly influence the treatment outcome of patient with EGFR-mutant NSCLC
por: Ju, Jia-Shiuan, et al.
Publicado: (2023)

Development and internal validation of a nomogram for predicting survival of nonoperative EGFR-positive locally advanced elderly esophageal cancers
por: Wang, Jiayang, et al.
Publicado: (2023)

Predicting EGFR Mutation in Lung Adenocarcinoma: Development and Validation of the EGFR Mutation Predictive Score (EMPS) in Bali, Indonesia
por: Njoto, Edwin Nugroho, et al.
Publicado: (2023)

Incorporating radiomic feature of pretreatment (18)F-FDG PET improves survival stratification in patients with EGFR-mutated lung adenocarcinoma
por: Chen, Yu-Hung, et al.
Publicado: (2020)

A Real-World Analysis of Patients with Untreated Metastatic Epidermal Growth Factor Receptor (EGFR)-Mutated Lung Adenocarcinoma Receiving First-Line Erlotinib and Bevacizumab Combination Therapy
por: Wang, Chin-Chou, et al.
Publicado: (2021)

Establishment of prognostic nomograms for predicting the progression free survival of EGFR‐sensitizing mutation, advanced lung cancer patients treated with EGFR‐TKIs
por: Du, Xinyang, et al.
Publicado: (2022)

Development of a Nomogram Based on 3D CT Radiomics Signature to Predict the Mutation Status of EGFR Molecular Subtypes in Lung Adenocarcinoma: A Multicenter Study
por: Zhang, Guojin, et al.
Publicado: (2022)

Development and validation of a novel nomogram to predict cancer-specific survival in patients with uterine cervical adenocarcinoma
por: Ni, Xiao, et al.
Publicado: (2021)

Development and validation of a nomogram for predicting survival in patients with surgically resected lung invasive mucinous adenocarcinoma
por: Zhang, Guochao, et al.
Publicado: (2021)

Development and validation of a nomogram to predict overall survival for cervical adenocarcinoma: A population-based study
por: Fa, Xin-yu, et al.
Publicado: (2023)

A validated survival nomogram for early-onset diffuse gastric cancer
por: Liao, Fei, et al.
Publicado: (2020)

A nomogram to predict survival probability of gastric cancer patients undergoing radical surgery and adjuvant chemotherapy
por: Ma, Ling, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j2bsr0sitp61jj5qgu2fcdssou